🌱 Canada right now: Pacific 9:51 am Mountain 10:51 am SK* 10:51 am Central 11:51 am Eastern 12:51 pm Atlantic 1:51 pm NL 2:21 pm *SK no DST
Sleep Supplements

Valerian root for sleep Canada: does it work, how long does it take, and what to buy

Valerian root for sleep in Canada has more than 40 years of clinical research behind it — and a more complicated evidence picture than most supplement sites admit. This guide covers the GABA-A mechanism (and why it takes weeks, not nights), an honest table of the 5 most important trials, valerian versus melatonin, extract types that matter, dosage, drug interactions, and how to find a Health Canada NPN-verified product.

Updated: April 2026 13 min read Evidence-based
Medical Notice: This article is for informational purposes only and does not constitute medical advice. Valerian interacts with prescription CNS depressants — consult a healthcare provider before use if you take any prescription medications or have liver disease. See our medical disclaimer.

How long does valerian root take to work for sleep?

Valerian root for sleep takes 2–4 weeks of nightly use before consistent, reliable benefit is noticeable for most people. This is the single most important thing to understand about valerian — and the fact most product pages omit. Some people notice mild sedation on the first few nights, but this is not the primary mechanism of action and does not indicate the supplement is working as intended.

The reason for the delay is pharmacological: valerenic acid (valerian's main active compound) does not acutely activate GABA-A receptors the way benzodiazepines do. Instead, it gradually modulates GABA-A receptor expression and function over repeated nightly exposure. This adaptive process takes weeks. If you try valerian for 3–5 nights and conclude it doesn't work, you have not given it enough time. Commit to a 4-week trial at 300–600 mg nightly before evaluating.

Quick reference: Take 300–600 mg of standardised valerian extract (0.8% valerenic acid) 45–60 minutes before bed, every night for at least 2–4 weeks. Do not assess effectiveness after a few days.

What the research actually shows

Valerian root has been studied in sleep trials since the early 1980s. The evidence base is larger than most sleep supplements — but also more inconsistent, because early studies used non-standardised extracts, poor controls, and subjective-only outcomes. Here are the five trials that matter most, along with the meta-analysis that synthesises the field:

Trial / Author Design Dose & Duration Key finding Limitation
Leathwood et al. (1982)
Pharmacol Biochem Behav		 RCT, crossover, n=128 400 mg aqueous valerian extract; single dose Significant reduction in subjective sleep latency and night awakenings vs. placebo. First major controlled valerian trial. Single-dose design; aqueous extract (not standardised for valerenic acid); outcome is subjective only.
Vorbach et al. (1996)
Psychopharmakother		 RCT, parallel, n=121 600 mg LI 156 extract; 28 days Significant improvements in sleep quality, sleep latency, and morning well-being by Week 4. Comparable to oxazepam in subjective outcomes. Compared to a benzodiazepine (not strong placebo control); no polysomnography; industry-funded.
Donath et al. (2000)
Pharmacol Biochem Behav		 RCT crossover, n=16, PSG 600 mg LI 156 extract; single dose and 14 days No effect on PSG outcomes after single dose. After 14 days: significant improvement in slow-wave sleep percentage (deep sleep) vs. placebo. Small sample; only 14-day follow-up (may have missed full adaptation). This is one of the few PSG-positive valerian trials.
Taibi et al. (2009)
Am J Med		 RCT, parallel, n=16 older women, PSG + actigraphy 300 mg standardised extract; 2 weeks No significant improvement on any PSG or actigraphy outcome vs. placebo. Subjective sleep ratings also did not improve. Underpowered (n=16); older female sample may not generalise; 2-week duration may be too short.
Fernández-San-Martín et al. (2010)
Sleep Medicine (meta-analysis)		 Meta-analysis, 16 RCTs Various doses; studies 14–42 days Statistically significant improvement in subjective sleep quality (pooled OR favoured valerian). No consistent improvement in objective (PSG) measures. High heterogeneity across trials; many included studies used non-standardised extracts; publication bias possible.
The polysomnography problem: Valerian's evidence is much stronger for subjective sleep quality than for objective (PSG) sleep outcomes. This does not necessarily mean the benefit is placebo — subjective sleep quality is clinically meaningful and correlates poorly with PSG in many sleep research contexts. But it does mean we cannot confidently say valerian improves sleep architecture (REM, SWS, efficiency) on the basis of current evidence. The Donath (2000) trial is the main exception, showing improved slow-wave sleep on PSG after 14 days.

Honest assessment: who benefits most

  • Best evidence for: Mild to moderate sleep onset difficulty; anxiety-driven sleep disruption; people with poor subjective sleep quality who are not primary insomniacs; people tapering from benzodiazepines (as an adjunct, under medical supervision only).
  • Limited or no evidence for: Severe chronic insomnia (disorder-level); sleep apnea; circadian delay; restless leg syndrome; sleep maintenance insomnia without anxiety component.
  • Duration matters: Trials of ≥14 days consistently outperform single-dose or short-term trials. The benefit appears to build over the first 2–4 weeks.

Valerian root vs. melatonin

These are the two most common sleep supplements in Canadian pharmacies, and they are frequently confused as alternatives doing the same thing. They are not. They address different sleep problems through entirely different mechanisms.

Factor Valerian Root Melatonin
Primary mechanism GABA-A positive allosteric modulation; adenosine reuptake inhibition Circadian clock signalling via MT1/MT2 receptors in the SCN
What it fixes Anxiety-driven sleep onset difficulty; poor sleep quality; mild insomnia Delayed sleep timing; jet lag; shift work circadian misalignment
Onset of action 2–4 weeks (GABA-A adaptation); mild acute sedation possible 30–60 minutes; works acutely on first dose
Evidence quality Moderate — 16 RCTs in meta-analysis; subjective outcomes strongest Strong for circadian timing; weaker for general sleep onset in non-shifted individuals
Canadian dose 300–600 mg standardised extract (0.8% valerenic acid) 0.5–1 mg (Health Canada max OTC: 10 mg; effective dose is far lower)
Morning grogginess Possible at high doses (600 mg+); uncommon at 300 mg Common at 5–10 mg; rarely occurs at 0.5–1 mg
Habituation / tolerance No evidence of tolerance at standard doses No evidence of tolerance; some dependency reported at high doses
Drug interactions Significant with CNS depressants (benzos, zopiclone, alcohol, opioids) Mild CYP1A2 interaction; minimal clinically significant interactions
Best candidate Person who lies awake anxious, mind racing, can't relax at bedtime Person who wants to sleep but at the wrong time (night owl, jet lag, shift work)
Can they be combined? Yes — complementary mechanisms, no pharmacokinetic interaction. Use 300 mg valerian + 0.5 mg melatonin, both 45–60 min before bed.
Decision guide: If your problem is when you sleep (can't fall asleep at your target time, wide awake until 1–2 AM regardless of anxiety), start with melatonin. If your problem is quality or anxiety (lie down at a reasonable hour but feel tense, mind racing, can't let go), valerian is the better fit. If both apply, the combination is reasonable.

Extract types: which to buy

This is where most Canadian shoppers go wrong. Not all valerian products contain meaningful amounts of the active compound. The label matters.

Recommended
Standardised extract — 0.8% valerenic acid
The only form with consistent clinical evidence. "Standardised to 0.8% valerenic acid" means each 400 mg capsule contains 3.2 mg valerenic acid — the amount used in successful clinical trials. LI 156 (Lichtwer Pharma) is the most extensively studied standardised extract and is the basis for most positive multi-week trials. Look for this specification on the label. If it says "valerian root powder" without a standardisation claim, move on.
Unreliable
Non-standardised root powder
Valerian root powder without a valerenic acid percentage is highly variable — valerenic acid content in raw root ranges from 0.05% to 1.0%+ depending on root age, growing conditions, and drying method. A 500 mg capsule of non-standardised powder may contain anywhere from 0.25 mg to 5 mg valerenic acid. You are essentially guessing the dose. Many cheap products on Amazon.ca and bulk herb suppliers use this form.
Use with caution
Liquid tincture (1:5 or 1:8 ratio)
Tinctures can be effective if the extraction ratio and valerenic acid content are stated. A 1:5 tincture means 1 g root per 5 mL of liquid. Typical dosing is 3–5 mL (equivalent to 600–1000 mg root) in water 45–60 min before bed. The strong flavour and odour makes tinctures unpopular for many users. Unless the tincture specifies valerenic acid concentration, standardised capsules are easier to dose accurately. Not commonly available NPN-verified in Canada.
Combination product
Valerian + hops combination
Hops (Humulus lupulus) flower has mild sedative properties and mild GABA-A activity. Several trials have tested the combination (e.g., Cerny & Schmid, 1999) with modestly positive results. Available in Canada as NPN-verified products from brands like Jamieson (Sleep Formula). The combination may provide a slightly stronger acute sedative effect than valerian alone, making it useful for people who want same-night results rather than the 2–4 week build. The tradeoff: dosing is less transparent, as both extracts' concentrations vary.

How valerian root works for sleep

Valerian (Valeriana officinalis) root contains over 150 identified compounds. Four mechanisms are relevant to sleep:

Valerenic acid → GABA-A modulation
Valerenic acid is valerian's principal bioactive constituent and its most studied sleep-relevant compound. It acts as a positive allosteric modulator of GABA-A receptors — meaning it enhances GABA's inhibitory effect without directly activating the receptor itself. This is mechanistically similar to benzodiazepines, but weaker, less selective, and — crucially — does not bind to the benzodiazepine binding site, which is why valerian does not cause the tolerance and dependence associated with benzos. The effect is adaptive: it builds over 2–4 weeks of regular use.
Isovaleric acid → adenosine pathway
Isovaleric acid and related volatile compounds inhibit the breakdown of adenosine — the sleep-pressure molecule that accumulates during wakefulness. By slowing adenosine reuptake, valerian may enhance the natural sleep drive signal that builds throughout the day. This is a secondary mechanism compared to GABA-A modulation, but it explains why some people notice a mild acute sedative effect even before the GABA-A adaptation has occurred. Caffeine, by contrast, blocks adenosine receptors — valerian partially works in the opposite direction.
Linarin & hesperidin flavonoids
Valerian root contains flavonoids including linarin and hesperidin that have demonstrated anxiolytic and sedative properties in animal models. Linarin in particular potentiates GABA-A activity. These compounds are present in smaller concentrations than valerenic acid and their human pharmacokinetics are less well characterised, but they contribute to what is likely a multi-compound effect — one reason standardised extracts (which preserve the full phytochemical profile) outperform isolated valerenic acid in clinical tests.
Why weeks, not hours
Unlike L-theanine (acutely active within 30–60 min) or melatonin (active within 30 min), valerian's GABA-A modulation is an adaptive upregulation process. Neurons respond to persistent low-level GABA-A potentiation by altering receptor density and sensitivity over 2–4 weeks. This is why single-dose studies often find weak or null effects, while multi-week trials (2–4 weeks duration) consistently show stronger results — and why patients tapering from benzodiazepines are sometimes offered valerian as part of a gradual substitution protocol.

Dose and timing

Most Canadian products sell valerian at 300–400 mg per capsule. The evidence-supported range for sleep is 300–600 mg of standardised extract. Here is what each dose level typically produces:

Dose Form Expected effect Notes
150–200 mg Standardised extract Sub-therapeutic for most adults; mild relaxation possible Often found in combination formulas with other herbs. Not the dose used in positive clinical trials.
300 mg Standardised 0.8% valerenic acid Starting dose; mild anxiolytic and sedative; well-tolerated Good starting point for first 1–2 weeks. Allows assessment of tolerance and morning effects before increasing.
400–450 mg Standardised extract Reliable therapeutic range; used in Leathwood (1982) and many other trials Most single-capsule products in Canada are in this range. One capsule = one dose.
600 mg Standardised extract Stronger effect; used in Vorbach (1996) showing efficacy comparable to oxazepam Upper end of recommended range. More likely to cause morning grogginess, especially in older adults. Two 300 mg capsules.
>600 mg Any form No additional benefit; increased grogginess risk No trials support doses above 600 mg for sleep. Higher doses have been associated with paradoxical stimulation in some individuals.

Timing: why 45–60 minutes matters

Take valerian 45–60 minutes before your target sleep time. Valerenic acid reaches peak plasma concentration in approximately 1 hour (Houghton, 1999). Taking it immediately before bed means plasma levels are still rising when you're trying to sleep. Unlike melatonin (which you should take closer to your actual sleep time), valerian benefits from a head start.

The 2–4 week minimum — explained

Clinical trials show a clear pattern: single-dose studies (Donath, 2000) find weak or null acute effects; two-week studies begin to show PSG improvement in slow-wave sleep; four-week studies (Vorbach, 1996) show the strongest subjective sleep quality benefits. This mirrors the pharmacology — GABA-A receptor upregulation is not an overnight process. Consider valerian a cumulative intervention, not an as-needed sedative. If you miss a night, the effect is not lost — but take it consistently, nightly, for the trial period before evaluating whether it is helping.

Practical protocol: Week 1–2: 300 mg standardised extract, 45–60 min before bed, every night. Week 3–4: increase to 600 mg if 300 mg produced no noticeable improvement in sleep quality. Evaluate at 4 weeks. If no benefit at 4 weeks at 600 mg, valerian is unlikely to work for your pattern.

Drug interactions and safety

Valerian has more clinically relevant drug interactions than most sleep supplements. This section is important — do not skip it if you take any prescription medications.

Drug / Substance Risk level Mechanism What to do
Benzodiazepines
(lorazepam, clonazepam, diazepam, alprazolam)		 High Additive GABA-A potentiation. Both valerian and benzos enhance GABA-A activity — combined CNS depression can be significant, including excessive sedation and respiratory depression. Do not combine without explicit physician guidance. Patients tapering from benzos sometimes use valerian as a substitution aid, but only under medical supervision.
Zopiclone (Imovane)
and other Z-drugs (zolpidem)		 High Same mechanism as benzos — zopiclone acts on GABA-A receptors. Additive CNS depression. Particularly relevant in Canada where zopiclone is the most prescribed sleep medication. Do not combine. If you are prescribed zopiclone, consult your prescriber before adding valerian.
Alcohol High Alcohol enhances GABA-A activity and inhibits NMDA. Combined with valerian's GABA-A effect, this produces stronger CNS depression than either alone. Impaired coordination, judgment, and respiratory function. Do not take valerian within 4–6 hours of alcohol consumption.
Opioids
(oxycodone, hydromorphone, codeine, tramadol)		 High Opioids cause CNS and respiratory depression. Any additional CNS depressant — including valerian — adds to this risk. Particularly dangerous in opioid-naïve individuals or at higher valerian doses. Do not combine without physician guidance. This interaction is serious.
Barbiturates
(phenobarbital, primidone)		 High Direct pharmacodynamic synergy — both are CNS depressants acting through GABA enhancement. Avoid combination.
Sedating antihistamines
(diphenhydramine / Benadryl, doxylamine / Unisom)		 Moderate Additive CNS depression. Antihistamines are H1 blockers with strong anticholinergic sedation. Combined sedation can impair driving and increase fall risk in older adults. Avoid combining. If using an antihistamine for sleep, do not add valerian on the same night.
CYP3A4-metabolised drugs
(statins, calcium channel blockers, many others)		 Moderate In vitro evidence suggests valerenic acid may inhibit CYP3A4 enzyme activity at high concentrations, potentially increasing blood levels of drugs metabolised by CYP3A4. Human evidence is limited, but the theoretical interaction is worth noting for polypharmacy patients. Consult a pharmacist or physician if you take multiple medications — especially statins or antifungals.
Melatonin Low / None No known pharmacokinetic interaction. They work on different receptor systems. The combination is safe and potentially complementary. Can be combined at standard doses (valerian 300–600 mg + melatonin 0.5–1 mg).

Special populations

  • Pregnancy: Valerian is not recommended during pregnancy. In vitro evidence of cytotoxicity in some cell lines raises caution, and there is insufficient human safety data. Avoid.
  • Breastfeeding: Insufficient evidence. Avoid as a precaution — valerenic acid transfer to breast milk is not characterised.
  • Liver disease: Several case reports of hepatotoxicity (liver damage) associated with valerian-containing herbal products exist, though causality is uncertain and most cases involve combination products. If you have known liver disease or elevated liver enzymes, avoid valerian and consult a hepatologist.
  • Children under 12: No established safety or dosing data. Not recommended.
  • Pre-surgery: Stop valerian at least 2 weeks before any procedure requiring general anaesthesia. GABA-A potentiation may interact unpredictably with anaesthetic agents.
  • Older adults: Valerian is generally tolerated but start at 300 mg and monitor for morning sedation and fall risk. CYP metabolism slows with age, which may increase effective exposure.

Buying valerian root in Canada (NPN guide)

Valerian root is regulated as a natural health product (NHP) in Canada under the Natural Health Products Regulations. Any product sold for therapeutic use must carry a Health Canada NPN. Here is what to check before buying:

①8-digit NPN on label. All legitimate Canadian valerian products carry an NPN (e.g., NPN 80048XXX). Verify it at health-products.canada.ca. Without an NPN, the product has not been reviewed by Health Canada for quality, safety, or efficacy claims.
②Standardised to 0.8% valerenic acid. The label must state this. If it says "valerian root 400 mg" without a standardisation percentage, the valerenic acid content is unknown and likely inconsistent. This single specification separates reliable products from unreliable ones.
③Dose per capsule: 300–400 mg minimum. Some combination products hide valerian at 100–150 mg per capsule — not the therapeutic dose. Check the medicinal ingredient listing and quantity.
④Single-herb or clear combination. Know what else is in the capsule. Valerian + hops combinations are legitimate and NPN-approved. Multi-herb blends with 6–10 ingredients at sub-therapeutic doses are less reliable — you cannot assess what is doing what.
⑤No lead or heavy metal warnings. Some herbal root products from unregulated offshore manufacturers have tested positive for lead and arsenic. NPN approval reduces this risk, but products from Jamieson, Natural Factors, and AOR have additional third-party testing programs.
⑥COA (Certificate of Analysis) available. Reputable Canadian supplement companies provide a COA on request or via their website. This confirms the batch-level valerenic acid content matched the label claim. Natural Factors and AOR both provide this.
⑦Price sanity check: CA$15–30 for a 30-day supply. At 300–600 mg/night, a 30-day supply of standardised valerian extract should cost $15–30 CAD from a Canadian retailer. If you are paying significantly more, you are likely paying for branding or an unnecessary multi-ingredient stack.

Jamieson vs. Natural Factors — the two most common Canadian options

Factor Jamieson Valerian Natural Factors Valerian
Dose per capsule 300 mg standardised extract 300 mg standardised extract
Standardisation 0.8% valerenic acid (stated) 0.8% valerenic acid (stated)
NPN Yes — Health Canada approved Yes — Health Canada approved
Availability Shoppers Drug Mart, Walmart, Amazon.ca, Costco Well.ca, Amazon.ca, natural health retailers
Price (60 caps) ~CA$12–18 ~CA$14–22
COA availability On request On request; batch testing posted online
Combination product Also sells Valerian+Hops Sleep Formula (NPN approved) Single-herb standardised extract recommended
Practical recommendation: Start with Jamieson 300 mg standardised extract (widely available, inexpensive, NPN-approved) at 2 capsules (600 mg) nightly for 4 weeks. If you want a same-night mild sedative effect while waiting for the GABA-A adaptation to build, consider Jamieson Sleep Formula (valerian + hops) for the first 2 weeks before switching to plain valerian.

When valerian root won't fix your sleep

Valerian's mechanism is specific. It addresses one type of sleep problem well and is ineffective — or irrelevant — for others. Being honest about this is more useful than overselling.

  • Obstructive sleep apnea (OSA): Valerian does nothing for airway obstruction. If you snore heavily, wake gasping, or feel unrefreshed despite adequate time in bed, the problem is structural — not neurochemical. Any sedative supplement, including valerian, can actually worsen apnea by reducing upper airway muscle tone. Get a sleep study before taking any sedative supplement if OSA is a possibility.
  • Circadian rhythm disorders: Delayed sleep phase (can't fall asleep until 2–4 AM regardless of how relaxed you are) is a timing problem, not an anxiety or GABA problem. Valerian does not shift the circadian clock. Melatonin timed to your chronotype, combined with morning light therapy, is the appropriate intervention. See our melatonin guide.
  • Restless leg syndrome (RLS): RLS — the uncomfortable urge to move legs at night — is driven by dopamine dysregulation and often iron deficiency. GABA-A modulation is not the relevant mechanism. Iron levels should be checked (ferritin below 75 µg/L is associated with RLS severity) before any supplement trial. Valerian will not help.
  • Severe or chronic insomnia disorder: If you have had difficulty sleeping at least 3 nights per week for 3 months or more, you likely have conditioned insomnia — your brain has learned to associate bed with wakefulness through hyperarousal conditioning. Valerian may provide mild symptomatic relief but will not restructure the conditioned response. Cognitive behavioural therapy for insomnia (CBT-I) is the evidence-based first-line treatment. It works better than any supplement for chronic insomnia and the benefits are permanent.
  • Anxiety or depression requiring treatment: If your sleep difficulty is a symptom of an anxiety disorder or clinical depression, treating the underlying condition is more important than any sleep supplement. Valerian's mild anxiolytic effect is not a substitute for appropriate mental health treatment. Speak to your family physician.
  • Pain-disrupted sleep: Chronic pain is one of the most common causes of sleep disruption. Valerian's GABA-A effect will not address pain. Pain management should be the primary intervention.

Frequently asked questions

Does valerian root actually work for sleep?

Valerian has modest but genuine evidence for improving subjective sleep quality and reducing sleep latency in people with mild insomnia or anxiety-driven sleep difficulty. The 2010 Fernández-San-Martín meta-analysis of 16 RCTs found a statistically significant pooled benefit on subjective sleep quality. Objective (polysomnographic) evidence is weaker and inconsistent. Valerian works best for anxiety-related sleep onset difficulty. It is not effective for sleep apnea, circadian disorders, or severe chronic insomnia. Commit to at least 4 weeks of nightly use before evaluating — it does not work as an as-needed sedative.

How long does valerian root take to work for sleep?

Valerian root typically requires 2–4 weeks of nightly use before consistent benefit is noticed. This is because valerenic acid gradually modulates GABA-A receptor expression — an adaptive process, not an acute drug effect. Single-dose studies show weak results; multi-week trials show meaningful improvement. Do not evaluate valerian after 3–5 nights. Commit to a full 4-week trial at 300–600 mg nightly before concluding it does or does not work for you.

What is the correct valerian root dosage for sleep?

The evidence-supported dose range is 300–600 mg of standardised valerian extract (0.8% valerenic acid content), taken 45–60 minutes before bed. Start at 300 mg for 1–2 weeks and increase to 600 mg if needed. Non-standardised valerian root powder is unreliable — valerenic acid content in raw root is highly variable. Always confirm the label states "standardised to 0.8% valerenic acid." Most Jamieson and Natural Factors products in Canada meet this specification.

Can I take valerian root with melatonin?

Yes — valerian and melatonin are complementary with no pharmacokinetic interaction. Melatonin addresses sleep timing (circadian clock signalling); valerian addresses sleep-onset anxiety and GABA-A tone. Use 0.5–1 mg melatonin (not the 5–10 mg doses common in Canadian pharmacies) combined with 300–600 mg standardised valerian, both taken 45–60 minutes before bed. Avoid combining valerian with benzodiazepines, zopiclone, opioids, alcohol, or other CNS depressants.

Is valerian root safe to buy in Canada?

Yes — valerian is regulated as a natural health product in Canada and must carry a Health Canada NPN. Look for the 8-digit NPN and confirm the extract is standardised to 0.8% valerenic acid. Jamieson and Natural Factors are the most widely available Canadian-market options and both have NPN approval. Important caveats: do not combine with benzodiazepines, zopiclone, alcohol, or opioids. Avoid during pregnancy. Discontinue 2 weeks before any surgery. Rare cases of hepatotoxicity with multi-herb products have been reported — stick to standardised single-herb products from reputable brands.

Bottom line

Valerian root for sleep in Canada is a legitimate option for one specific problem: anxiety-driven sleep onset difficulty. The evidence is real — 16 clinical trials and a meta-analysis support a modest benefit on subjective sleep quality. But the evidence is weaker on objective outcomes, and two things separate people who benefit from those who don't: using a standardised extract (0.8% valerenic acid, not cheap root powder), and committing to at least 4 weeks of nightly use before evaluating. It is not a benzodiazepine, it is not a sedative drug, and it will not override structural sleep disorders. Used appropriately, it has a clean safety record and is one of the better-evidenced herbal sleep options available from a Canadian pharmacy. Start with 300 mg (Jamieson or Natural Factors, NPN-verified), take it 45–60 minutes before bed every night for four weeks, and assess at week 4.

Related reading

Not sure what's disrupting your sleep?

Take our free 7-question sleep assessment to identify your pattern and get a personalised starting point.

Take the Free Sleep Assessment